Changzhou Ruiming Pharmaceutical Co., Ltd. is located at No. 1558, Longjiang North Road, Chunjiang Town, Xinbei District, Changzhou City, Jiangsu Province, and was established in 2004. 　　The company is adjacent to the Yangtze River and Shanghai-Nanjing Expressway, with convenient transportation and superior environment. 　　The company occupies an area of ​​25,000 square meters. At present, the company has 9 main buildings: three chemical synthesis workshops, a refined drying package workshop (in compliance with GMP requirements), a liquid raw material warehouse, a solid raw material warehouse (separated into raw and auxiliary materials warehouse, intermediate warehouse and finished product warehouse), power Room, machine repair room, office building and living building. 　　The company implements GMP requirements for all activities involved in the production and quality management process. 　　 So far, there are three APIs, which passed the domestic GMP inspections in July 2009, July 2011 and July 2015; propafenone hydrochloride, felodipine and amlodipine besylate. Among them, amlodipine besylate obtained the CEP certificate of EOQM in August 2011, and obtained the updated CEP certificate in August 2016. In May 2017, it passed the on-site audit of the European Union, and in December 2017, it passed the on-site audit of the Japanese PMDA. 　　 "Technology and Innovation" is the company's continuous and eternal pursuit. The company focuses on the improvement of research and development technology, has introduced a group of outstanding talents, and has established good cooperative relations with China Pharmaceutical University, Shanghai Higher Education Institutions, etc. in terms of product technology. 　　 Sincerely welcome customers from all over the world to contact our company, explore opportunities for cooperation, and seek common development with integrity.

Registered Capital:  15 million

Registered Address:  No. 1558, Longjiang North Road, Chunjiang Town, Xinbei District, Changzhou City

Company Type:  MPR

Business Scope:  Pharmaceutical manufacturing and sales (operating with a license); manufacturing and sales of p-hydroxyphenylacetone; import and export of goods or technologies (except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval). (Projects that are subject to approval in accordance with the law can be operated only after being approved by relevant departments)